CLOUDBREAK PHARMA INC. - B
(HKEX: 2592)
Cloudbreak Pharma, Inc. is an investment holding company, which engages in the research and development of therapeutic biologics. Its pipeline includes CBT-001, CBT-009, CBT-004, CBT-006, CBT-199, CBT-145, CBT-007, and CBT-011. The company was founded by Jin Song Ni, Van Son Dinh, and Jun Zhi Li in September 2015 and is headquartered in Irvine, CA.
2.540 -
+0.050
(+2.01%)
Range
2.450 - 2.540
(3.67%)
Open
2.510
Previous Close
2.490
Bid Price
2.530
Bid Volume
('000)
1
Ask Price
2.540
Ask Volume
('000)
52.5
Volume
('000)
542.5
Value
1,356,560
Remark
-
Delayed prices. Updated at 29 Jan 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
